The Journal of Immunology and Inflammatory Diseases aims to advance understanding of immune system function and dysregulation by publishing high-quality, peer-reviewed research that bridges basic immunology, translational science, and clinical investigation. The journal seeks to foster innovation in areas such as innate and adaptive immunity, immune signaling pathways, autoimmune and inflammatory disorders, and host–pathogen interactions, while encouraging interdisciplinary collaboration across immunology, molecular biology, genetics, microbiology, and clinical medicine. By supporting the development of novel immunotherapies, biomarkers, and diagnostic approaches, the journal provides a platform for discoveries that enhance disease prevention, diagnosis, and treatment. Emphasis is placed on translational relevance, mechanistic insight, and clinical impact to address immune-mediated diseases and inflammatory conditions. Its open-access model ensures global accessibility, enabling the scientific and medical communities to benefit from its findings.

Its scope includes cellular and molecular immunology, autoimmune diseases, chronic and acute inflammation, allergy and hypersensitivity, immunodeficiency, and immunotherapy. The journal also highlights interdisciplinary research in vaccinology, infectious disease immunology, cancer immunology, and inflammatory signaling networks, fostering advancements in both fundamental understanding and clinical application.

Articles can be submitted via email 📧:(or) online through our official submission porta 🌐: